-
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
11 Feb 2025 15:06 GMT
… is the most neuroendocrine lung tumor, and it also … Lung cancers associated with cystic airspaces: CT features and pathologic correlation. Lung Cancer … -L1 expression in rare lung tumors. Pathol Oncol Res. … phase II study of sunitinib in recurrent and…
-
Solid Tumor Therapeutics Market Report 2024–2033 | USD 408.47B Size | CAGR of 7.70% Growth
26 Jun 2025 13:23 GMT
… Type: Prostate Cancer, Colorectal Cancer, Lung Cancer, Breast Cancer, Cervical Cancer, … Gemcitabine, Paclitaxel, Doxorubicin, Bevacizumab, Erlotinib, Sunitinib, Everolimusa, Others
By End-user … of advanced non-small cell lung cancer (NSCLC), one of the …
-
Lenvatinib Plus Pembrolizumab Delays Tumor Progression in All Organs vs Sunitinib in Advanced RCC
05 Jun 2024 18:17 GMT
… in all organs vs sunitinib (Sutent) in patients with advanced … organ groups. In the lung tumor group, the median time … lenvatinib and pembrolizumab compared with sunitinib,” Viktor Grünwald, MD, … of patients who received sunitinib,” Grünwald said in conclusion …
-
Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
22 Jan 2024 22:20 GMT
… seeing sustained benefits over sunitinib in the primary … node positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non–small cell lung cancer, …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises … chemotherapy for small cell lung cancer. Lung Cancer. 2006;52(3 … sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108– …
-
Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
26 May 2022 21:17 GMT
… demonstrated deeper responses vs sunitinib. Regardless of treatment, … non-small cell lung cancer (NSCLC)
Lung cancer is one of … of lung cancer - NSCLC and SCLC (small cell lung cancer). … Organization: GLOBOCAN 2020 – Lung Cancer: Estimated cancer incidence, …
-
HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer
07 Mar 2022 06:00 GMT
… savolitinib plus IMFINZI® versus sunitinib monotherapy versus IMFINZI® … caregivers/lung-cancer-101/types-of-lung-cancer . Accessed … lung cancer – A systematic review and meta-analysis. Lung Cancer 2018 … non-small-cell lung cancers harbouring MET exon …
-
HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor Therapy
24 Nov 2021 01:15 GMT
… ;s lung cancer patients are in China.3 Lung cancer is … savolitinib plus IMFINZI® versus sunitinib monotherapy versus IMFINZI® … caregivers/lung-cancer-101/types-of-lung-cancer . Accessed June … other non-small-cell lung cancers harbouring MET exon …
-
Global Lung Cancer Drugs Market Trends, Strategies, And Opportunities In The Lung Cancer Drugs Market 2021-2030
13 Sep 2021 10:54 GMT
… lung cancer drugs market, lung cancer drugs market share, lung cancer drugs market players, lung cancer … drugs market segments and geographies, lung cancer … Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor ( …
-
LENVIMA Plus KEYTRUDA Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib
26 May 2023 11:04 GMT
… meaningful OS benefit
versus sunitinib, reducing the risk of … the
superior results versus sunitinib from the primary OS … and ORR
compared to sunitinib. These findings reinforce the … hepatocellular carcinoma, non-small cell lung cancer, RCC,
head and neck …
About
© 1995-2025